ScaleUp Bio is a Singapore-based startup aiming to support global food tech start-ups in scaling up their operations. The company provides contract development and manufacturing organization (CDMO) services in microbial precision fermentation, emphasizing sustainable food solutions and ingredients. Their services cover the entire journey of start-ups from process optimization to scale-up, with up to 10,000 L fermentation capacity in their dedicated food-grade facilities. ScaleUp Bio leverages collaborative partnerships with key entities including ADM (Archer Daniel Midlands) and Nurasa (formerly Asia Sustainable Foods Platform, wholly owned by Temasek). This joint venture is driven by the mission to accelerate the commercialization and adoption of sustainable food across Asia. Their partnerships extend to collaborative research and development with Singapore’s Agency for Science Technology and Research (A*STAR), engagement with the food tech community at Nurasa’s Food Tech Innovation Centre (FTIC) and the Food Application Lab with ADM. Although specific investment details are not available at the moment, the company's pioneering efforts in the Food and Beverage sector and their strategic collaborations position them as a noteworthy prospect for potential future investment. For more information on how ScaleUp Bio can enable businesses to scale to success, individuals can visit their website at www.scaleupbio.com or contact them at [email protected]. The company's focus on enabling sustainable solutions in the food tech industry, combined with their innovative collaborations, makes them an intriguing entity for potential investment opportunities.
There is no investment information
No recent news or press coverage available for ScaleUp Bio.